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INTRODUCTION: Acute kidney injury usually develops in critically ill patients in the context of multiple organ dysfunctions.
OBJECTIVE: To evaluate the effect of changes in associated organ dysfunctions over the first three days of renal replacement 
therapy on the outcomes of patients with acute kidney injury.
METHODS: Over a 19-month period, we evaluated 260 patients admitted to the intensive care units of three tertiary-care hospitals 
who required renal replacement therapy for > 48 h. Organ dysfunctions were evaluated by SOFA score (excluding renal points) 
on the first (D1) and third (D3) days of renal replacement therapy. Absolute (A-SOFA) and relative (∆-SOFA) changes in SOFA 
scores were also calculated.
RESULTS: Hospital mortality rate was 75%. Organ dysfunctions worsened (A-SOFA>0) in 53%, remained unchanged (A-SOFA=0) 
in 17% and improved (A-SOFA<0) in 30% of patients; and mortality was lower in the last group (80% vs. 84% vs. 61%, p=0.003). 
SOFA on D1 (p<0.001), SOFA on D3 (p<0.001), A-SOFA (p=0.019) and ∆-SOFA (p=0.016) were higher in non-survivors. How-
ever, neither A-SOFA nor ∆-SOFA discriminated survivors from non-survivors on an individual basis. Adjusting for other covari-
ates (including SOFA on D1), A-SOFA and ∆-SOFA were associated with increased mortality, and patients in whom SOFA scores 
worsened or remained unchanged had poorer outcomes.
CONCLUSIONS: In addition to baseline values, early changes in SOFA score after the start of renal replacement therapy were 
associated with hospital mortality. However, no prognostic score should be used as the only parameter to predict individual out-
comes.
KEYWORDS: Sequential Organ Failure Score. Dialysis. Acute kidney injury. Mortality. Outcome.
INTRODUCTION
Acute kidney injury (AKI) occurs frequently in critically 
ill patients, and despite advances in intensive care and renal 
replacement therapies (RRT) in recent years, mortality 
rates remain exceedingly high.1-5 Many predictive factors 
for increased mortality have been identified in recent years, 
including older age, the need for RRT itself, the severity of 
comorbidities and associated organ failures.1-4,6
AKI usually develops in critically ill patients in the 
context of multiple organ dysfunctions.3 Organ dysfunction 
scores are routinely used to evaluate these states in critically 
ill patients. Although no single characteristic or prognostic 
score should be used as only parameter to predict outcome 
on individual basis, the sequential evaluation of changes in 
organ dysfunctions during the first days of admission has been 
shown to refine outcome prediction in patients admitted to the 
intensive care unit (ICU).7-9 However, studies focusing on this 
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topic in patients with AKI requiring RRT are both scant and 
limited by a retrospective design and relatively small sample 
size.10,11 The aim of the present study was to evaluate the effect 
of changes in associated organ dysfunctions over the first three 
days of RRT on the outcomes of a large cohort of patients 
admitted to the ICU with AKI.
METHODS 
From December 2004 to May 2006, a prospective cohort 
study was performed at the medical-surgical ICU of three 
tertiary-care hospitals. Since this study did not interfere with 
clinical decisions related to patients’ care, the Institutional 
Review Board approved it and waived the need for informed 
consent in all centers.
Study Participants, Data Collection and Definitions
During the study period, every patient with AKI or acute 
on chronic kidney injury in need of RRT was evaluated. AKI 
was classified according to the RIFLE criteria12 at the time 
of initiation of RRT. Patients with end-stage renal disease 
requiring chronic dialysis, those with non-renal indications 
for RRT and those who received RRT in the ICU for < 48 h 
or had an ICU stay < 48 h were not considered. For patients 
with readmissions, only the first admission was considered. 
Decisions to start, change the method, and cease RRT were 
made by the nephrologist and the intensivist responsible for 
the patient on an individual basis. Prescribed RRT modes 
were daily conventional dialysis, daily extended dialysis 
and continuous RRT (CRRT), taking into consideration 
the patient’s hemodynamic status.4 CRRT was employed 
for patients receiving vasoactive drugs and for those with 
potential for hemodynamic instability. Oliguria was defined 
as urine output <400 ml/day.
Associated acute organ dysfunctions were evaluated by 
calculating the Sequential Organ Failure Assessment (SOFA) 
score,13 excluding renal points. For sedated patients, the 
Glasgow Coma Scale (GCS) prior to sedation was used.14 
SOFA scores were determined on the first (D1) and on 
the third (D3) days of RRT. The absolute (A-SOFA) and 
relative (∆-SOFA) changes in SOFA scores over the first 
three days of RRT were determined as follows: A-SOFA 
= SOFA on D3 – SOFA on D1; and ∆-SOFA = (SOFA on 
D3 – SOFA on D1) / SOFA on D1. Patients with missing 
data for the calculation of SOFA scores on D1 or D3 were 
also excluded from the analysis. Patients were classified 
according to the A-SOFA into three categories: “improved” 
(A-SOFA < 0), “remained unchanged” (A-SOFA = 0) and 
“worsened” (A-SOFA > 0). In addition, the following data 
were collected: age, gender, the Simplified Acute Physiology 
Score (SAPS) II15 at ICU admission, previous health status,16 
comorbidities,17 main reasons for ICU admission, pre-
morbid renal function, need of mechanical ventilation and 
vasopressors for more than 24 h and contributing factors 
for AKI. The Charlson Comorbidity Index was used in the 
measurement of comorbidities.17 Sepsis was diagnosed using 
the criteria developed at the American College of Chest 
Physicians/Society of Critical Care Medicine consensus 
conference,18 and infection was diagnosed using criteria from 
the Centers for Diseases Control.19 Hospital mortality was 
the end-point of interest. End-of-life decisions (to withhold 
or withdraw life-support treatments) were made in regard to 
patients who did not recover from the acute illness despite 
full-code management.
Data Presentation and Statistical Analysis
Standard descriptive statistics were used to describe 
the study population. Continuous variables are presented 
as mean ± standard deviation or median (25%-75% 
interquartile range). Univariate and multivariate logistic 
regression analyses were used to identify factors associated 
with hospital mortality. Linearity between continuous 
variables and the dependent variable was evaluated using 
locally weighted scatterplot smoothing (LOWESS).20 
Variables yielding P values <0.2 by univariate analysis and 
variables considered clinically important were entered in a 
forward multivariate logistic regression analysis. Results of 
both uni- and multivariate analyses were summarized by 
estimating odds ratios (OR) and respective 95% confidence 
intervals (CI). Possible interactions and colinearity were 
tested. The area under the receiver operating characteristic 
curve (AROC) was used to evaluate the ability of the models 
to discriminate between patients who lived and those who 
died (discrimination).21 The Hosmer-Lemeshow goodness-
of-fit test was used to evaluate the model calibration.20 A 
two-tailed P < 0.05 was considered statistically significant.
RESULTS
 
Characterization of the Study Population
A total of 429 patients were admitted to the ICUs and 
required RRT during the study period. Of these patients, 71 
(17%) received chronic dialysis for end-stage renal disease, 
68 (16%) received RRT in the ICU for < 48 h and 30 (7%) 
had missing data for the calculation of SOFA scores; as 
a result, all 169 were excluded from the study. Among 
patients who received RRT and stayed in the ICU for < 48 
h, six (9%) survived and were discharged to the wards. No 
patient received RRT for non-renal indication. Therefore, 
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the remaining 260 (61%) patients constituted the study 
population. The main characteristics of patients are depicted 
in Table 1. The most frequent reasons for ICU admission 
were sepsis (n=162, 62%), postoperative complications 
(n=28, 11%), cardiovascular complications (n=25, 
10%), AKI (n=10, 4%), trauma (n=8, 3%), neurological 
complications (n=8, 3%) and miscellaneous (n=19, 7%). 
Patients were admitted to the ICU at a median of 0 (0-2) 
days after hospital admission.
The main contributing factors for AKI were sepsis 
(77%), ischemia/shock (67%), contrast/nephrotoxins (29%), 
major surgeries (22%), rhabdomyolysis (5%), urinary tract 
obstruction (4%) and other reasons (5%) (a patient could 
have more than one reason for AKI). CRRT was the initial 
modality of RRT in 222 (85%) patients. The median time to 
the start of RRT was three (0-8) days after ICU admission. 
Ninety-one (35%) patients received RRT the first day in the 
ICU, and 159 (65%) did thereafter.
The median SOFA score (except renal points) on D1 
was six (4-8) points and on D3 was seven (4-9) points. 
Table 1 - Main demographic and clinical characteristics of patientsa
Variables All patients 
(n=260)
A-SOFA < 0 
[n=79 (30)]
A-SOFA = 0 
[n=44 (17)]
A-SOFA > 0 
[n=137 (53)]
p-value b
Age (years) 72.9±14.8 70.7±17.1 74.8±15.2 73.5±13.2 0.265
Male sex 135 (52) 34 (43) 29 (66) 72 (53) 0.051 c
Hospital days prior to ICU admission (n) 0 (0 – 2) 0 (0 – 2) 0 (0 – 9) 0 (0 – 2) 0.713
Medical admission 209 (80) 68 (86) 39 (89) 102 (75) 0.037
Poor chronic health status (Knaus C or D) 114 (44) 32 (41) 22 (50) 60 (44) 0.596
Charlson Comorbidity Index (points) 3 (1 – 4) 2 (1 – 4) 3 (2 – 5) 3 (1 – 4) 0.149
Charlson Comorbidity Index >1 point 222 (85) 63 (80) 41 (93) 118 (86) 0.121
Body mass index (Kg/m2) 26.0±5.0 26.0±4.6 25.5±3.8 26.2±5.6 0.741
SAPS II (ICU admission, points) 47.5±10.6 46.5±11.4 48.6±9.7 47.7±10.4 0.551
SOFA on day 1 of RRT (except renal points) 5.7±3.1 6.3±3.0 5.5±3.6 5.3±2.9 0.073 d
SOFA on day 3 of RRT (except renal points) 6.4±3.5 4.1±3.0 5.5±3.6 8.0±2.9 <0.001 c,ddd,eee
A-SOFA (SOFA D3 – SOFA D1) (points) 1 (-1 – 2) -2 (-3 – -1) 0 (0 – 0) 2 (1 – 4) <0.001 ccc,ddd,eee
∆-SOFA (SOFA D3 – SOFA D1 / SOFA D1) 0.1 (-1.4 – 0.3) -0.3 (0.5 – -0.2) 0 (0 – 0) 0.3 (0.2 – 0.8) <0.001 ccc,ddd,eee
RIFLE categories
 Risk 68 (26) 23 (29) 8 (18) 37 (27) 0.676
 Injury 65 (25) 18 (23) 11 (25) 36 (26)
 Failure 127 (49) 38 (48) 25 (57) 64 (47)
Chronic kidney injury 88 (34) 29 (37) 20 (46) 39 (29) 0.095 e
RRT at the first day of ICU 91 (35) 30 (38) 15 (34) 46 (34) 0.800
Oliguria 72 (29) 29 (30) 11 (25) 40 (29) 0.812
Sepsis 200 (77) 66 (84) 33 (75) 101 (74) 0.243
Mechanical ventilation 210 (81) 62 (79) 31 (71) 117 (85) 0.075 e
Vasopressors 186 (71) 53 (67) 28 (64) 105 (77) 0.144
Length of ICU stay (days) 19 (10 – 37) 19 (13 – 37) 23 (11 – 38) 19 (9 – 35) 0.477
Length of hospital stay (days) 26 (14 – 50) 31 (16 – 52) 30 (16 – 66) 22 (11 – 45) 0.122 d
Decision to withhold/withdraw treatment 43 (17) 10 (13) 8 (20) 25 (19) 0.524
ICU mortality 185 (71) 44 (56) 34 (77) 107 (75) 0.001 c,ddd
Hospital mortality 194 (75) 48 (61) 37 (84) 109 (80) 0.003 c,dd
a
 Results expressed as mean ±SD, median (IQR), n (%).
b
 Comparison among different categories of changes in associated organ failures based on A-SOFA.
c
 p<0.05, cc p<0.01, ccc p<0.001 for comparisons between patients in whom organ failures improved (A-SOFA < 0) or remained unchanged (A-SOFA = 0).
d
 p<0.05, dd p<0.01, ddd p<0.001 for comparisons between patients in whom organ failures improved (A-SOFA < 0) or worsened (A-SOFA > 0).
e
 p<0.05, ee p<0.01, eee p<0.001 for comparisons between patients in whom organ failures remained unchanged (A-SOFA = 0) or worsened (A-SOFA > 0).
SD = standard deviation, IQR = interquartile range; ICU=intensive care unit; SAPS=Simplified Acute Physiology Score; SOFA=Sequential Organ Fail-
ure Assessment; RRT = renal replacement therapy
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The following organ dysfunctions (> 1 point in each 
domain) were observed on D1: respiratory (n=207, 80%), 
cardiovascular (n=189, 73%), hematological (n=120, 46%), 
hepatic (n=45, 17%) and neurological (n=19, 7%). The 
median A-SOFA was one (-1 – 2) point, and the median 
∆-SOFA was 0.1 (-1.4 – 0.3). According to the A-SOFA, 
organ dysfunctions improved in 79 (30%), remained 
unchanged in 44 (17%) and worsened in 137 (53%) patients. 
Comparisons among the categories of A-SOFA scores are 
depicted in Table 1. Baseline (D1) organ dysfunctions were 
more severe in “improved” patients. “Worsened” patients had 
a lower frequency of medical admission. In general, there 
were not important differences in patients’ characteristics 
among the groups (Table 1).
Outcome analysis
The overall ICU and hospital mortality rates were 71% 
and 75%, respectively. The main outcome data for patients 
are presented in Table 1. Non-survivors were older than 
survivors (75.4±12.9 vs. 65.5±17.6 years, P<0.001) and had 
higher Charlson comorbidity scores [3 (2 – 4) vs. 2 (0 – 4), 
P=0.023]. As is predictable, SAPS II (49.2±9.7 vs. 42.5±11.5, 
P<0.001), SOFA D1 [6 (4 – 8) vs. 5 (2 – 7), P=0.011] and 
SOFA D3 [7 (5 – 9) vs. 5 (1 – 7), P<0.001] scores were 
higher in decedents than in survivors. A-SOFA [1 (0 – 2) vs. 
0 (-2 – 0), P=0.019] and ∆-SOFA [0.11 (0.02 – 0.38) vs. 0 
(-0.33 – 0.25), P=0.016] were also higher in non-survivors 
(Figures 1a and 1b). However, neither the SAPS II score 
[AROC = 0.69 (95% CI = 0.61 – 0.76)], the A-SOFA [AROC 
= 0.60 (95% CI = 0.52 – 0.68)] nor the ∆-SOFA [AROC = 
0.60 (95% CI = 0.52 – 0.68)] discriminate survivors from 
non-survivors on an individual basis. In Figure 2, the mortality 
rates for the different possibilities of the A-SOFA according to 
Figure 1 - Boxplot graphics representing the comparisons of absolute (A-SOFA) [Figure 1a] and relative (∆-SOFA) [Figure 1b] changes in associated organ 
failures between survivors and non-survivors. P-values refer to the Mann-Whitney U test.
Figure 2 - Hospital mortality rates (y-axis) according to the degree of se-
verity of organ failures on Day 1. The values corresponding to the terciles 
of distribution of the SOFA score on Day 1 (SOFA D1) (x-axis) were used 
to establish a cut-off point for stratifying the patients into three groups 
(columns). Patients in whom associated organ failures improved (A-SOFA 
< 0), remained unchanged (A-SOFA = 0) and worsened (A-SOFA > 0) are 
represented in gray, square-lined and black columns, respectively. a) P = 
0.05; b) P = 0.19; c) P = 0.04.
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the different degrees of severity of organ failures at baseline 
(SOFA-D1) are depicted. The values corresponding to the 
terciles of distribution of the SOFA score on D1 (SOFA D1) 
were used to establish a cut-off point to stratify the patients 
into three groups. The hospital mortality was significantly 
higher in patients in whom organ dysfunction worsened or 
remained unchanged.
The results of univariate analysis of predictive factors for 
increased hospital mortality are depicted in Table 2. Older 
age, poor chronic health status, presence of comorbidities, 
body mass index, SOFA D1, A-SOFA, ∆-SOFA and A-SOFA 
categories were associated with a worse outcome. Three 
multivariate analyses were performed, entering either 
A-SOFA, ∆-SOFA or A-SOFA categories in separate models 
(Table 3). The main independent outcome predictors were 
older age, the presence of comorbidities, poor functional 
capacity, baseline organ dysfunctions (SOFA D1) and all 
forms of evaluation of changes in organ dysfunctions. 
Patients in whom organ dysfunction worsened or remained 
unchanged had a worse outcome adjusting for other 
Table 2 - Univariate analysis of factors associated with increased hospital mortality (n=260)
Variables Mortality 
(%)
Odds-ratios 
(95% CI)
p-value
Age (years) - 1.04 (1.02 – 1.06) <0.001
Gender
   Female 71 1.00 0.282
   Male 78 1.42 (0.81 – 2.48)
Poor chronic health status (Knaus C or D)
   No 62 1.00 <0.001
   Yes 90 5.66 (2.79 – 11.47)
Charlson comorbidity index (points)
   0 50 1.00 <0.001
   ≥ 1 79 3.72 (1.83 – 7.59)
Type of admission
   Surgical 67 1.00 0.202
   Medical 77 1.63 (0.84 – 3.17)
Days prior to ICU admission (Ln) - 1.058 (0.90 – 1.30) 0.426
Mechanical ventilation
   No 74 1.00 0.999
   Yes 75 1.04 (0.52 – 2.11)
Sepsis
   No 70 1.00 0.443
   Yes 76 1.36 (0.72 – 2.58)
Vasopressors
   No 68 1.00 0.135
   Yes 76 1.62 (0.91 – 2.90)
Acute on chronic kidney injury
   No 74 1.00 0.801
   Yes 76 1.13 (0.62 – 2.05)
RRT on the first day in ICU
   No 78 1.00 0.107
   Yes 68 0.60 (0.34 – 1.06)
Oliguria
   No 73 1.00 0.425
   Yes 79 1.37 (0.72 – 2.59)
SOFA D1 - 1.13 (1.03 – 1.25) 0.009
A-SOFA - 1.13 (1.01 – 1.26) 0.038
∆-SOFA - 1.26 (0.86 – 1.84) 0.231
A-SOFA categories
   Improved (< 0) 61 1.00 0.003
   Remained unchanged (= 0) 84 3.41 (1.35 – 8.61)
   Worsened (> 0) 80 2.51 (1.36 – 4.64)
CI = confidence interval; ICU = intensive care unit; SOFA = Sequential Organ Failure Assessment.
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significant covariates. All multivariate models had both 
good calibration and discrimination (Table 3). Sepsis, acute 
on chronic kidney dysfunction and oliguria were forced into 
the final models and were not selected. The SAPS II score 
Table 3 - Multivariate analyses of factors associated with 
increased hospital mortality (n=260)
Variables Odds-ratios 
(95% CI)
P value
Model including A-SOFA a
Age (years) 1.03 (1.01 – 1.06) 0.021
Charlson comorbidity index (points)
   0 1.00
   ≥ 1 3.84 (1.57 – 9.39) 0.003
Poor chronic health status (Knaus C or D)
   No 1.00
   Yes 3.37 (1.49 – 7.65) 0.004
Type of admission
   Surgical 1.00 0.049
   Medical 2.27 (1.00 – 5.13)
SOFA D1 1.32 (1.16 – 1.49) <0.001
A-SOFA 1.27 (1.10 – 1.46) 0.001
Model including ∆-SOFA b
Age (years) 1.03 (1.00 – 1.06) 0.024
Charlson comorbidity index (points)
   0 1.00
   ≥ 1 3.38 (1.41 – 8.08) 0.006
Poor chronic health status (Knaus C or D)
   No 1.00
   Yes 3.90 (1.74 – 8.75) 0.001
SOFA D1 1.31 (1.16 – 1.48) <0.001
∆-SOFA 1.84 (1.16 – 2.91) 0.009
Model including A-SOFA categories c
Age (years) 1.03 (1.00 – 1.06) 0.022
Charlson comorbidity index (points)
   0 1.00
   ≥ 1 3.34 (1.37 – 8.14) 0.008
Poor chronic health status (Knaus C or D)
   No 1.00
   Yes 3.60 (1.58 – 8.22) 0.002
Type of admission
   Surgical 1.00 0.066
   Medical 2.15 (0.96 – 4.87)
SOFA D1 1.29 (1.14 – 1.45) <0.001
A-SOFA categories
   Improved (< 0) 1.00
   Remained unchanged (= 0) 4.29 (1.45 – 12.72) 0.009
   Worsened (> 0) 4.07 (1.91 – 4.87) <0.001
CI = confidence interval; SOFA = Sequential Organ Failure Assessment.
a
 AROC = 0.81 (95% CI = 0.75-0.87); Hosmer-Lemeshow goodness-of-fit 
(χ2=4.144; P=0.844).
b
 AROC = 0.72 (95% CI = 0.65-0.80); Hosmer-Lemeshow goodness-of-fit 
(χ2=8.234; P=0.411).
c
 AROC = 0.73 (95% CI = 0.66-0.80); Hosmer-Lemeshow goodness-of-fit 
(χ2=6.241; P=0.620).
was also entered into the final models (OR=1.02 (0.98-1.06), 
p=0.267 in the model which included the A-SOFA; OR=1.02 
(0.98-1.06), p=0.241 in the model which included the 
∆-SOFA; OR=1.02 (0.98-1.06), p=0.258 in the model which 
included the A-SOFA categories). The SAPS II score was 
not selected in all of them, and in general, the effects of the 
other covariates remained unchanged.
DISCUSSION 
Although changes in organ dysfunctions have already 
been reported to be associated with outcomes in general 
ICU patients22, information on this subject in patients with 
AKI is limited. Patients with AKI have higher mortality 
rates, especially when RRT is required, and their outcomes 
are significantly worse than those of other patients.1-5 It has 
long been known that prognostic scores or even specific 
renal scores used at ICU admission do not perform well in 
the AKI population.23,24 In the present multicenter study, 
we have prospectively investigated the effect of early 
changes in associated organ dysfunctions on the mortality 
of a large cohort of critically ill patients with AKI in need 
of RRT. We employed the SOFA score, a simple, validated 
and widely used organ dysfunction score for this purpose. 
Our results demonstrated that, in addition to well-known 
outcome predictors, such as older age, medical admission, 
a poor previous chronic health status, comorbidities and the 
severity of baseline organ dysfunctions, the sequential trend 
in associated organ dysfunctions over the first three days 
of RRT was associated with increased hospital mortality. 
However, it was also demonstrated that these trends in 
organ dysfunctions as a single parameter were not able 
to discriminate survivors and non-survivors and that they 
therefore should not be used to predict outcome on an 
individual basis.
Previous studies have reported that the outcomes of 
patients with AKI are worse in the context of multiple 
organ dysfunctions and that mortality rates increase with 
the number of organ dysfunctions.1,4 Organ dysfunctions are 
an ongoing event changing over the clinical course of ICU 
patients, and their evaluation at a static point may not always 
reflect the real patient’s clinical condition. Changes in SOFA 
scores over the first 24 h or 48 h have been demonstrated 
to refine outcome prediction in patients with severe sepsis8 
and in general ICU patients,7 respectively. Chertow et al.25 
reported an enhanced prediction power with the sequential 
analysis of different prognostic scores, including SOFA 
score, in the AKI population.
Although it is intuitive that the course of associated 
organ dysfunctions correlates with outcomes in patients with 
AKI in need of RRT, to the best of our knowledge only two 
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previous studies have addressed this issue.10,11
Kikuchi et al.11 evaluated 40 patients who underwent 
different extracorporeal blood purification procedures. 
However, in addition to patients with AKI receiving RRT 
(45% of the entire population), they also evaluated patients 
treated with plasma exchange, bilirubin and endotoxin 
adsorption. In accord with our results, they demonstrated 
that although changes in SOFA scores did not discriminate 
mortality on an individual basis, non-survivors had higher 
maximum SOFA scores and higher changes in SOFA scores 
during RRT procedures than survivors.
More recently, Cappi et al.10 retrospectively evaluated 111 
patients with AKI in need of RRT. In that study, independent 
predictors of increased ICU mortality were cardiovascular 
dysfunction at ICU admission, changes in total SOFA scores 
over the first 24 h of ICU stay and older age. However, as 
acknowledged by the authors, the study was limited by 
its retrospective design and by a relatively small sample 
size. In addition, many other outcome predictors such as 
comorbidities and chronic health status, which would be 
interesting to adjust for, were not evaluated.
In a very elegant study, Levy et al.8 evaluated the 
impact of changes in total SOFA score and its domains 
over the first 24 h in 1,034 patients with severe sepsis. They 
demonstrated that improvements in organ dysfunctions 
correlated significantly with survival. By contrast, patients in 
whom organ dysfunctions remained unchanged or worsened 
presented with comparatively higher 28-day mortality rates. 
These observations are in agreement with our results. In 
our study, the multivariate analysis showed four-fold higher 
odds of hospital mortality in patients with AKI in whom the 
associated organ failures remained unchanged or worsened 
in comparison to those in whom organ failures improved. 
These facts remained significant even when the patients 
were stratified according to the severity of baseline organ 
dysfunctions.
Nonetheless, there are some limitations in our study 
which must be taken into account in the generalization of 
its results. First, although patients from three tertiary-care 
centers were included, the study was restricted to a specific 
geographic area. Moreover, the decision to start RRT was 
left at the discretion of the attending nephrologist and 
intensivist. Even though it is reasonable to presume that the 
criteria employed in this study are similar to those accepted 
in many ICUs, indications for RRT vary significantly 
among institutions. Due to the non-interventional nature 
of the present study, it is not possible to conclude whether 
changes in organ failures over time can be used to evaluate 
the response to RRT. In a recent report, Sakr et al.26 
have demonstrated the applicability of daily renal SOFA 
score analysis as an evaluation tool for starch effects in 
renal function. However, it should be emphasized that no 
prognostic score, including severity of organ failure scores, 
can be used as the only parameter in decisions related to the 
patient’s care. Another criticism to consider is that SOFA 
scores should ideally have been collected daily while RRT 
was used. However, the decision to measure changes in 
SOFA scores on D1 and D3 was made based on the study of 
Ferreira et al.7 In that study, changes in SOFA score over the 
first 48 h better predicted mortality than changes observed 
on the subsequent days did. Finally, the mortality rates of 
our patients were high. However, our patient population is 
significantly old (69% of the patients were older than 70 
years), 85% had comorbidities and 44% had poor chronic 
health status. Older age, severity of comorbidities and 
poor chronic health status are well-known risk factors for 
increased mortality in critically ill patients.
Our results indicate that early changes in SOFA score 
after the start of RRT were associated with hospital mortality 
of patients with AKI. Adjusting for other relevant covariates, 
including the initial severity of organ dysfunctions, patients 
in whom SOFA scores worsened or remained unchanged 
had poorer outcomes. On the other hand, a decrease in 
SOFA score over the first three days of RRT was associated 
with improved survival in patients with AKI. In conjunction 
with clinical judgment, and taking into consideration the 
patient’s preferences and values, the knowledge of these 
outcome predictors may be useful in helping physicians 
make decisions in the care of these patients and in improving 
discussions of a patient’s prognosis. However, changes in 
SOFA scores did not discriminate outcomes on an individual 
basis and should not be used as a single parameter for 
predicting outcomes and evaluating patients’ response to 
therapeutic interventions such as RRT.
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